LeaderPortfolio
Mehta
Satish Mehta
Rank #2235
INDIAHealthcarePharmaceuticals

Satish Mehta

Net Worth
$1.858B
0% (24h)
Satish Mehta is a prominent figure in the pharmaceutical industry and a successful entrepreneur. He is the founder of Emcure Pharmaceuticals, one of India's leading pharmaceutical companies, and has built a diverse portfolio of investments. His career spans over four decades, during which he has overseen Emcure's growth into a global enterprise with operations in over 70 countries. Mehta's net worth reflects his successful ventures in pharmaceuticals and his ability to build and expand the company. He is recognized for his commitment to making healthcare accessible and affordable.

The Full Dossier

Early Life and Education

Satish Mehta's journey began with a vision to revolutionize healthcare in India. After graduating from IIM Ahmedabad, he decided to embark on an entrepreneurial path, setting the stage for Emcure Pharmaceuticals. His father was a pharma retailer, which gave him early insights into the industry.

Rise to Success

Founded in 1981 with a loan of ₹3 lakh, Emcure Pharmaceuticals rapidly grew under Satish Mehta's leadership. The company initially focused on contract manufacturing and gradually expanded into branded generics. Under his leadership, Emcure became a leading pharmaceutical company in India and then expanded globally.

Key Business Strategies

Mehta's leadership emphasized innovation and strategic acquisitions. Emcure invested significantly in research and development and expanded its product portfolio through both organic growth and strategic acquisitions. This approach helped the company enter global markets, particularly the US. Furthermore, Emcure went public in July 2024, listed at a premium, to further its expansion.

Philanthropy

Satish Mehta believes in giving back to society. Emcure sponsors life-saving surgeries, supports education for underprivileged students, and has adopted villages to promote environmental sustainability. His PRERNA initiative empowers women employees, and the NEEM scheme boosts skill development, reinforcing Emcure's commitment to community. Also, Mehta has been recognized with the 'India for Humanity' initiative.

Career Timeline

2024

Emcure Pharmaceuticals listed on the stock exchange

Emcure was listed at a 31% premium.

2005-2006

Entered regulated markets

Emcure started building operations in various countries.

1994

Sun Pharma listed on the stock exchange

Sun Pharma was listed on the stock exchange with an oversubscribed issue.

1981

Founded Emcure Pharmaceuticals

Started Emcure as a contract manufacturer for multinationals.

Philanthropic Impact

HealthcareUndisclosed

Sponsorship of life-saving surgeries

Emcure supports medical initiatives.

EducationUndisclosed

Education for underprivileged students

Supports educational programs.

EnvironmentalUndisclosed

Village adoption and environmental sustainability

Promoting awareness about environmental sustainability.

Social EmpowermentUndisclosed

PRERNA initiative

Empowers women employees

Skill DevelopmentUndisclosed

NEEM scheme

Boosts skill development.

Wealth Trajectory